Enliven Therapeutics, Inc. (ELVN)
Nasdaq: ELVN · Pharmaceutical Preparations · Boulder, CO · filing with the SEC since 2016
The company now
Enliven Therapeutics, Inc. is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in Boulder, CO. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported a loss of $104 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.